Trump announces deal with drugmakers to lower cost of weight loss drugs
President Trump announced drugmakers Novo Nordisk and Eli Lilly have agreed to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound.
Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients
Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients Search Select Category All News Articles Briefings & Statements All Presidential Actions Executive Orders Nominations & Appointments Presidential Memoranda Proclamations Fact Sheets Remarks Research All Articles Briefings & Statements Presidential Actions All Executive Orders Nominations & Appointments Presidential Memoranda […]
Dr. Oz rushes to aid Novo Nordisk exec after weight-loss drug chief frighteningly collapses at White House following Trump’s GLP-1 briefing: Live blog
As the US government shutdown continues to reach historic lengths, the FAA is looking to reduce traffic at 40 major airports amid staffing shortages.
Trump Strikes Deal to Cut Cost of Weight Loss Drugs.
PULSE POINTS WHAT HAPPENED: President Donald J. Trump has cut a deal to lower the price of certain weight loss drugs. WHO WAS INVOLVED: President Trump, Eli Lilly, and Novo Nordisk officials. WHEN & WHERE: The announcement was made on Thursday. KEY QUOTE: “This is a triumph for American patients that will save lives and […]
Happening Now: Trump Makes Announcement On Weight Loss Drug Prices
President Trump on Thursday morning is set to announce new deals he made with drugmakers Eli Lilly and Novo Nordisk that would lower the price of some GLP-1 weight loss medications. Trump’s strategy to lower prescription drug prices has been put to the test in recent months after he rolled out an executive order earlier […]
Protein, AI, GLP-1 drugs and more… What are the biggest trends shaping the beverage industry of tomorrow?
The beverage industry is rapidly evolving with trends focusing on health and wellness, driven by innovations like GLP-1 drugs and functional beverages offering benefits from cognitive enhancement to female health.
From Progression to Remission: A New Paradigm for Success in Chronic Kidney Disease
Recent advances in treatment of chronic kidney disease (CKD) have changed the clinical paradigm from slowing inevitable progression to achievable remission. Landmark trials involving SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and targeted immunotherapies for IgA nephropathy demonstrate that sustained eGFR preservation and normalization of albuminuria are now realistic goals in both diabetic and glomerular […]
Watch live: Trump makes announcement on weight loss drug prices
President Trump on Thursday morning is set to announce new deals he made with drugmakers Eli Lilly and Novo Nordisk that would lower the price of some GLP-1 weight loss medications. Trump’s strategy to lower prescription drug prices has been put to the test in recent months after he rolled out an executive order earlier […]
Radioactive Shrimp, Ozempic Allegations: The MedPage Today Culture Awards
(MedPage Today) — We’ve nominated medicine’s biggest culture makers and moments of 2025, it’s your turn to vote
‘BeanTok’ trend goes viral with wild gut health promises — here’s what experts say
A new TikTok trend promising better gut health is gaining steam — but experts caution this viral movement may come with some unpleasant side effects. In an online community known as “BeanTok,” users are hyping two cups of beans a day as the next big wellness trend. From black beans to lentils and chickpeas, videos […]